Cardiorespiratory screening in elite endurance sports athletes: The Québec study

Physician and Sportsmedicine

Volumn 40, Issue 3, 2012, Pages 55-65

  Turmel, Julie ^a   Poirier, Paul ^a   Bougault, Valérie ^b   Blouin, Evelyne ^a   Belzile, Mireille ^c   Boulet, Louis Philippe ^a  

^a LAVAL UNIVERSITY   (Canada)

^b Faculté des Sciences du Sport et de l'Éducation Physique   (France)

^c PCN Physiotherapy Clinic   (Canada)

Author keywords

Athletes; Cardiorespiratory diseases; Sport preparticipation evaluation

Indexed keywords

METHACHOLINE; DIAGNOSTIC AGENT; METHACHOLINE CHLORIDE;

ADULT; AEROBIC CAPACITY; AIRBORNE PARTICLE; ARTICLE; ASTHMA; ATHLETE; BLOOD PRESSURE MONITORING; BLOOD SAMPLING; CARDIORESPIRATORY DISORDER; CONTROLLED STUDY; ELECTROCARDIOGRAPHY; ENDURANCE SPORT; EXERCISE TEST; FEMALE; HEART DISEASE; HOLTER MONITORING; HUMAN; HYPERTENSION; HYPERVENTILATION; INHALATION TEST; MAJOR CLINICAL STUDY; MALE; PHYSICAL EXAMINATION; PREVALENCE; QUESTIONNAIRE; RESPIRATORY TRACT ALLERGY; RESPIRATORY TRACT DISEASE; SCREENING; SPIROMETRY; ADOLESCENT; BRONCHUS HYPERREACTIVITY; CANADA; EXERCISE INDUCED ASTHMA; MASS SCREENING; METHODOLOGY; PATHOPHYSIOLOGY; SKIN TEST;

ADOLESCENT; ADULT; ASTHMA, EXERCISE-INDUCED; ATHLETES; BLOOD PRESSURE MONITORING, AMBULATORY; BRONCHIAL HYPERREACTIVITY; BRONCHIAL PROVOCATION TESTS; ELECTROCARDIOGRAPHY; ELECTROCARDIOGRAPHY, AMBULATORY; EXERCISE TEST; FEMALE; HUMANS; HYPERTENSION; HYPERVENTILATION; MALE; MASS SCREENING; METHACHOLINE CHLORIDE; PHYSICAL EXAMINATION; PREVALENCE; QUEBEC; QUESTIONNAIRES; SKIN TESTS;

EID: 84873937027     PISSN: 00913847     EISSN: None     Source Type: Journal    
DOI: 10.3810/psm.2012.09.1982     Document Type: Article

References (63)

1. Irvine C, Taylor NF. Progressive resistance exercise improves glycaemic control in people with type 2 diabetes mellitus: a systematic review. Austr J Physiother. 2009;55(4):237-246.
2. Manfredini F, Malagoni AM, Mandini S, et al. Sport therapy for hypertension: why, how, and how much? Angiology. 2009;60(2):207-216.
3. Nici L, Donner C, Wouters E, et al. American Thoracic Society/European Respiratory Society Statement on Pulmonary Rehabilitation. Am J Respir Crit Care Med. 2006;173(12):1390-1413.
4. Donnelly JE, Blair SN, Jakicic JM, Manore MM, Rankin JW, Smith BK. Appropriate physical activity intervention strategies for weight loss and prevention of weight regain for adults. Med Sci Sports Exerc. 2009;41(2):459-471.
5. Franklin BA, Whaley MH, Howley ET, et al; American College of Sports Medicine. Guidelines for Exercise Testing and Prescription. 6th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2000.
6. Thompson PD, Franklin BA, Balady GJ, et al; American College of Sports Medicine. Exercise and acute cardiovascular events placing the risks into perspective: a scientific statement from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism. Circulation. 2007;115(17):2358-2368.
7. Turcotte H, Langdeau JB, Thibault G, Boulet LP. Prevalence of respiratory symptoms in an athlete population. Respir Med. 2003;97:955-963.
8. Vancamp SP, Bloor CM, Mueller FO, Cantu RC, Olson HG. Nontraumatic sports death in high school and college athletes. Med Sci Sports Exerc. 1995;27(5):641-647.
9. Corrado D, Basso C, Thiene G. Sudden cardiac death in athletes: what is the role of screening? Curr Opin Cardiol. 2012; 27(1):41-48.
10. Corrado D, Basso C, Schiavon M, Pelliccia A, Thiene G. Pre-participation screening of young competitive athletes for prevention of sudden cardiac death. J Am Coll Cardiol. 2008;52(24):1981-1989.
11. Mahler DA. Exercise-induced asthma. Med Sci Sports Exerc. 1993;25 (5):554-561.
12. American College of Sports Medicine. Guidelines for Exercise Testing and Prescription. 6th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2009.
13. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2011;34(suppl 1):S62-S69.
14. Nielsen P, Nachtigall D. Iron supplementation in athletes. Current recommendations. Sports Med. 1998;26(4):207-216.
15. Gardner RM, Hankinson JL. Standardization of spirometry: 1987ATS update. J Occup Environ Med. 1988;30(3):272-273.
16. Knudson RJ, Lebowitz MD, Holberg CJ, Burrows B. Changes in the normal maximal expiratory flow-volume curve with growth and aging. Am Rev Respir Dis. 1983;127:725-734.
17. Argyros GJ, Roach JM, Hurwitz KM, Eliasson H, Phillips YY. Eucapnic voluntary hyperventilation as a bronchoprovocation technique-a development of a standardized dosing schedule in asthmatics. Chest. 1996;109(6):1520-1524.
18. Anderson SD, Brannan JD. Methods for "indirect" challenge tests including exercise, eucapnic voluntary hyperpnea, and hypertonic aerosols. Clin Rev Allergy Immunol. 2003;24(1):27-54.
19. Juniper EF, Cockcroft DW, Kolendowicz R. Histamine and Methacholine Inhalation Tests: Tidal Breathing Method; Laboratory Procedure and Standardization. Lund, Sweden: Astra Draco AB; 1994.
20. World Anti-Doping Agency. Medical information to support the decision of TUECs Asthma. Montreal, QC, Canada: World Anti-Doping Agency; 2011.
21. Lougheed MD, Lemiere C, Dell SD, et al. Canadian Thoracic Society Asthma Management Continuum-2010 Consensus Summary for children six years of age and over, and adults. Can Respir J. 2010;17(1):15-24.
22. Myers J, Buchanan N, Smith D, et al. Individualized ramp treadmill. Observations on a new protocol. Chest. 1992;101(suppl 5):S236-S241.
23. Pescatello LS, Franklin BA, Fagard R, et al. American College of Sports Medicine position stand. Exercise and hypertension. Med Sci Sports Exerc. 2004;36(3):533-553.
24. Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003;289(19):2560-2572.
25. Corrado D, Pelliccia A, Bjornstad HH, et al. Cardiovascular pre-participation screening of young competitive athletes for prevention of sudden death: proposal for a common European protocol: consensus statement of the study group of sport cardiology of the working group of cardiac rehabilitation and exercise physiology and the working group of myocardial and pericardial diseases of the European Society of Cardiology. Eur Heart J. 2005;26(5):516-524.
26. Beckerman J, Wang P, Hlatky M. Cardiovascular screening of athletes. Clin J Sport Med. 2004;14(3):127-133.
27. Garrick JG. Preparticipation orthopedic screening evaluation. Clin J Sport Med. 2004;14(3):123-126.
28. McCrory P. Preparticipation assessment for head injury. Clin J Sport Med. 2004;14(3):139-144.
29. Fallon KE. Utility of hematological and iron-related screening in elite athletes. Clin J Sport Med. 2004;14(3):145-152.
30. Holzer K, Brukner P. Screening of athletes for exercise-induced bronchoconstriction. Clin J Sport Med. 2004;14(3):134-138.
31. Rumball JS, Lebrun CM. Preparticipation physical examination-selected issues for the female athlete. Clin J Sport Med. 2004;14(3):153-160.
32. Manfreda J, Sears MR, Becklake MR, et al. Geographic and gender variability in the prevalence of bronchial responsiveness in Canada. Chest. 2004;125(5):1657-1664.
33. Langdeau JB, Turcotte H, Bowie DM, Jobin J, Desgagne P, Boulet LP. Airway hyperresponsiveness in elite athletes. Am J Respir Crit Care Med. 2000;161(5):1479-1484.
34. Rundell KW, Slee JB. Exercise and other indirect challenges to demonstrate asthma or exercise-induced bronchoconstriction in athletes. J Allergy Clin Immunol. 2008;122(2):238-246.
35. Parsons JP, Kaeding C, Phillips G, Jarjoura D, Wadley G, Mastronarde JG. Prevalence of exercise-induced bronchospasm in a cohort of varsity college athletes. Med Sci Sports Exerc. 2007;39(9):1487-1492.
36. Gibson GJ, Greenacre JK, Konig P, Conolly ME, Pride NB. Use of exercise challenge to investigate possible tolerance to beta-adrenoceptor stimulation in asthma. Br J Dis Chest. 1978;72(3):199-206.
37. Ramage L, Lipworth BJ, Ingram CG, Cree IA, Dhillon DP. Reduced protection sgainst exercise-induced bronchoconstriction after chronic dosing with salmeterol. Respir Med. 1994;88(5):363-368.
38. Inman MD, Obyrne PM. The effect of regular inhaled albuterol on exercise-induced bronchoconstriction. Am J Respir Crit Care Med. 1996;153(1):65-69.
39. Simons FER, Gerstner TV, Cheang MS. Tolerance to the bronchoprotective effect of salmeterol in adolescents with exercise-induced asthma using concurrent inhaled glucocorticoid treatment. Pediatrics. 1997;99(5):655-659.
40. Nelson JA, Strauss L, Skowronski M, Ciufo R, Novak R, McFadden ER. Effect of long-term salmeterol treatment on exercise-induced asthma. N Engl J Med. 1998;339(3):141-146.
41. Garcia R, Guerra P, Feo F, et al. Tachyphylaxis following regular use of formoterol in exercise-induced bronchospasm. J Investig Allergol Clin Immunol. 2001;11(3):176-182.
42. Hancox RJ, Subbarao P, Kamada D, Watson RM, Hargreave FE, Inman MD. B-2-agonist tolerance and exercise-induced bronchospasm. Am J Respir Crit Care Med. 2002;165(8):1068-1070.
43. Chan-Yeung M, Anthonisen NR, Becklake MR, et al. Geographical variations in the prevalence of atopic sensitization in six study sites across Canada. Allergy. 2010;65(11):1404-1413.
44. Katelaris CH, Carrozzi FM, Burke TV, Byth K. A springtime Olympics demands special consideration for allergic athletes. J Allergy Clin Immunol. 2000;106(2):260-266.
45. Katelaris CH, Carrozzi FM, Burke TV, Byth K. Patterns of allergic reactivity and disease in Olympic athletes. Clin J Sport Med. 2006;16(5):401-405.
46. Helenius IJ, Tikkanen HO, Sarna S, Haahtela T. Asthma and increased bronchial responsiveness in elite athletes: atopy and sport event as risk factors. J Allergy Clin Immunol. 1998;101(5):646-652.
47. Bousquet PJ, Chinn S, Janson C, Kogevinas M, Burney P, Jarvis D. Geographical variation in the prevalence of positive skin tests to environmental aeroallergens in the European Community Respiratory Health Survey I. Allergy. 2007;62:301-309.
48. Arbes SJ, Gergen PJ, Elliott L, Zeldin DC. Prevalences of positive skin test responses to 10 common allergens in the US population: Results from the Third National Health and Nutrition Examination Survey. J Allergy Clin Immunol. 2005;116(2):377-383.
49. Laprise C, Boulet LP, Morissette J, Winstall E, Raymond V. Evidence for association and linkage between atopy, airway hyper-responsiveness, and the beta subunit Glu237Gly variant of the high-affinity receptor for immunoglobulin E in the French-Canadian population. Immunogenetics. 2000;51(89):695-702.
50. Guerra S, Sherrill DL, Martinez FD, Barbee RA. Rhinitis as an independent risk factor for adult-onset asthma. J Allergy Clin Immunol. 2002;109(3):419-425.
51. Leddy JJ, Izzo J. Hypertension in athletes. J Clin Hypertens (Greenwich). 2009;11(4):226-233.
52. Pelliccia A, Maron BJ, De Luca R, Di Paolo FM, Spataro A, Culasso F. Remodeling of left ventricular hypertrophy in elite athletes after long-term deconditioning. Circulation. 2002;105(8):944-949.
53. Dlin RA, Hanne N, Silverberg DS, Baror O. Follow-up of normotensive men with exaggerated blood-pressure response to exercise. Am Heart J. 1983;106(2):316-320.
54. Singh JP, Larson MG, Manolio TA, et al. Blood pressure response during treadmill testing as a risk factor for new-onset hypertension. The Framingham Heart Study. Circulation. 1999;99(14):1831-1836.
55. Matthews CE, Pate RR, Jackson KL, et al. Exaggerated blood pressure response to dynamic exercise and risk of future hypertension. J Clin Epidemiol. 1998;51(1):29-35.
56. Tanji JL. Tracking of elevated blood-pressure values in adolescent athletes at 1-year follow-up. Am J Dis Child. 1991;145(6):665-667.
57. Manolio TA, Burke GL, Savage PJ, Sidney S, Gardin JM, Oberman A. Exercise blood pressure response and 5-year risk of elevated blood pressure in a cohort of young ddults: the CARDIA study. Am J Hypertens. 1994;7(3):234-241.
58. Nakashima M, Miura K, Kido T, et al. Exercise blood pressure in young adults as a predictor of future blood pressure: a 12-year follow-up of medical school graduates. J Hum Hypertens. 2004;18(11):815-821.
59. Beard J, Tobin B. Iron status and exercise. Am J Clin Nutr. 2000;72(2 suppl):594S-597S.
60. Haas JD, Brownlie T. Iron deficiency and reduced work capacity: a critical review of the research to determine a causal relationship. J Nutr. 2001;131(2S-2):676S-688S.
61. Fogelholm M. Indicators of vitamin and mineral status in athletes blood: a review. Int J Sport Nutr. 1995;5(4):267-284.
62. La Société Québécoise D'hypertension Artérielle. Hypertension: Guide thérapeutique. 3rd ed. Montreal, QC, Canada: La Société Québécoise D'hypertension Artérielle; 2007.
63. American College of Sports Medicine. Guidelines for Exercise Testing and prescription. 7th ed. Baltimore, MD: Lippincott Williams & Wilkins; 2005.